Caveolae: From cell biology to animal physiology

Pharmacological Reviews

Volumn 54, Issue 3, 2002, Pages 431-467

  Razani, Babak ^a   Woodman, Scott E ^a   Lisanti, Michael P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CHOLESTEROL; DYSTROPHIN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN; NITRIC OXIDE SYNTHASE;

BIOCHEMISTRY; BIOGENESIS; CANCER; CARCINOGENESIS; CAVEOLA; CELL PROLIFERATION; CHEMICAL COMPOSITION; COMPLEX FORMATION; CYTOLOGY; ENDOCYTOSIS; HOMEOSTASIS; HUMAN; LUNG; MEMBRANE STRUCTURE; MORPHOLOGY; MULTIGENE FAMILY; NONHUMAN; OLIGOMERIZATION; ONCOGENE; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNTHESIS; TISSUE SPECIFICITY; TRANSCYTOSIS; TRANSVERSE TUBULAR SYSTEM; TUMOR SUPPRESSOR GENE;

ANIMALS; CAVEOLAE; CAVEOLINS; CELL MEMBRANE; CHOLESTEROL; DISEASE MODELS, ANIMAL; EVOLUTION, MOLECULAR; HUMANS; MICE; MUTATION; NEOPLASMS; ONCOGENES; SIGNAL TRANSDUCTION;

EID: 0036733284     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.54.3.431     Document Type: Review

References (291)

1. Abumrad NA, Park JH, and Park CR (1984) Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity and evidence for involvement of a membrane protein. J Biol Chem 259:8945-8953.
2. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, and Krieger M (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science (Wash DC) 271:518-520.
3. Anderson HA, Chen Y, and Norkin LC (1996) Bound simian virus 40 translocates to caveolin-enriched membrane domains and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 7:1825-1834.
4. Anderson RG, Kamen BA, Rothberg KG, and Lacey SW (1992) Potocytosis: sequestration and transport of small molecules by caveolae. Science (Wash DC) 255:410-411.
5. Anderson RGW (1998) The caveolae membrane system. Annu Rev Biochem 67:199-225.
6. Annabi B, Lachambre M, Bousquet-Gagnon N, Page M, Gingras D, and Beliveau R (2001) Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. Biochem J 353:547-553.
7. Arakawa R, Abe-Dohmae S, Asai M, Ito JI, and Yokoyama S (2000) Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells. J Lipid Res 41:1952-1962.
8. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RGW, Xu S, and Krieger M (1997) Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 272:13242-13249.
9. Basu S and Kolesnick R (1998) Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene 17:3277-3285.
10. Bathori G, Parolini I, Tombola F, Szabo I, Messina A, Oliva M, De Pinto V, Lisanti M, Sargiacomo M, and Zoratti M (1999) Porin is present in the plasma membrane where it is concentrated in caveolae and caveolae-related domains. J Biol Chem 274:29607-29612.
11. Benlimame N, Le PU, and Nabi IR (1998) Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum. Mol Biol Cell 9:1773-1786.
12. Bernlohr DA, Coe NR, and LiCata VJ (1999) Fatty acid trafficking in the adipocyte. Semin Cell Dev Biol 10:43-49.
13. Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V, Torbergsen T, Lee YA, Nothen MM, Wienker TF, et al. (2001) Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 28:218-219.
14. Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, and Lodish HF (1997) Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem 272:13793-13802.
15. Biederer CH, Ries SJ, Moser M, Florio M, Israel MA, McCormick F, and Buettner R (2000) The basic helix-loop-helix transcription factors myogenin and Id2 mediate specific induction of caveolin-3 gene expression during embryonic development. J Biol Chem 275:26245-26251.
16. Bilderback TR, Grigsby RJ, and Dobrowsky RT (1997) Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J Biol Chem 272:10922-10927.
17. Bist A, Fielding PE, and Fielding CJ (1997) Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci USA 94:10693-10698.
18. Bonilla E, Fischbeck K, and Schotland DL (1981) Freeze-fracture studies of muscle caveolae in human muscular dystrophy. Am J Pathol 104:167-173.
19. Brenman JE, Chao DS, Xia H, Aldape K, and Bredt DS (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743-752.
20. Brown D and Rose JK (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68:533-544.
21. Brown DA and London E (1998) Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136.
22. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, and Sessa WC (2000) In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6:1362-1367.
23. Bush KT, Stuart RO, Li SH, Moura LA, Sharp AH, Ross CA, and Nigam SK (1994) Epithelial inositol 1,4,5-triphosphate receptors. Multiplicity of localization, solubility and isoforms. J Biol Chem 269:23694-23699.
24. Calvo M, Tebar F, Lopez-Iglesias C, and Enrich C (2001) Morphologic and functional characterization of caveolae in rat liver hepatocytes. Hepatology 33:1259-1269.
25. Cameron PL, Ruffin JW, Bollag R, Rasmussen H, and Cameron RS (1997) Identification of caveolin and caveolin-related proteins in the brain. J Neurosci 17:9520-9535.
26. Carbone I, Bruno C, Sotgia F, Bado M, Broda P, Masetti E, Panella A, Zara F, Bricarelli FD, Cordone G, et al. (2000) Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 54:1373-1376.
27. Carman CV, Lisanti MP, and Benovic JL (1999) Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem 274:8858-8864.
28. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, and Shaul PW (2000) Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87:E44-E52.
29. Chang WJ, Ying YS, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, De Gunzburg J, Mumby SM, Gilman AG, and Anderson RG (1994) Purification and characterization of smooth muscle cell caveolae. J Cell Biol 126:127-138.
30. Chun M, Liyanage U, Lisanti MP, and Lodish HF (1994) Signal transduction of a G-protein coupled receptor in caveolae: Colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci, USA 91:11728-11732.
31. Colledge M and Scott JD (1999) AKAPs: from structure to function. Trends Cell Biol 9:216-221.
32. Conrad PA, Smart EJ, Ying YS, Anderson RGW, and Bloom GS (1996) Caveolin cycles between the plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J Cell Biol 131:1421-1433.
33. Couet J, Li S, Okamoto T, Ikezu T, and Lisanti MP (1997a) Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272:6525-6533.
34. Couet J, Sargiacomo M, and Lisanti MP (1997b) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272:30429-30438.
35. Crawley J, Lupu F, Westmuckett AD, Severs NJ, Kakkar VV, and Lupu C (2000) Expression, localization and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 20:1362-1373.
36. Crosbie RH, Yamada H, Venzke DP, Lisanti MP, and Campbell KP (1998) Caveolin-3 is not an essential component of the dystrophin glycoprotein complex. FEBS Lett 427:279-282.
37. Cui J, Rohr LR, Swanson G, Speights VO, Maxwell T, and Brothman AR (2001) Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 46:249-256.
38. Czarny M, Lavie Y, Fiucci G, and Liscovitch M (1999) Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains. Modulation by caveolin-1 expression and caveolin-1 82-101. J Biol Chem 274:2717-2724.
39. Daniel EE, Jury J, and Wang YF (2001) nNOS in canine lower esophageal sphincter: colocalized with Cav-1 and Ca2+-handling proteins. Am J Physiol Gastrointest Liver Physiol 281:G1101-G1114.
40. Darby PJ, Kwan CY, and Daniel EE (2000) Caveolae from canine airway smooth muscle contain the necessary components for a role in Ca(2+) handling. Am J Physiol Lung Cell Mol Physiol 279:L1226-L1235.
41. Das K, Lewis RY, Scherer PE, and Lisanti MP (1999) The membrane spanning domains of caveolins 1 and 2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo. J Biol Chem 274:18721-18728.
42. de la Llera-Moya M, Rothblat GH, Connelly MA, Kellner-Weibel G, Sakr SW, Phillips MC, and Williams DL (1999) Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res 40:575-580.
43. DeGrella RF and Simoni RD (1982) Intracellular transport of cholesterol to the plasma membrane. J Biol Chem 257:14256-14262.
44. Demeule M, Jodoin J, Gingras D, and Beliveau R (2000) P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett 466:219-224.
45. Dietzen DJ, Hastings WR, and Lublin DM (1995) Caveolin is palmitoylated on multiple cysteine residues: Palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem 270:6838-6842.
46. Donati RJ, Thukral C, and Rasenick MM (2001) Chronic treatment of C6 glioma cells with antidepressant drugs results in a redistribution of Gsalpha. Mol Pharmacol 59:1426-1432.
47. Dormans JA (1983) The ultrastructure of various cell types in the lung of the rat: a survey. Exp Pathol 24:15-33.
48. Doyle DD, Goings G, Upshaw-Earley J, Ambler SK, Mondul A, Palfrey HC, and Page E (2000) Dystrophin associates with caveolae of rat cardiac myocytes: relationship to dystroglycan. Circ Res 87:480-488.
49. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, et al. (2001) Loss of caveolae, vascular dysfunction and pulmonary defects in caveolin-1 gene-disrupted mice. Science (Wash DC) 293:2449-2452.
50. Dupree P, Parton RG, Raposo G, Kurzchalia TV, and Simons K (1993) Caveolae and sorting of the trans-Golgi network of epithelial cells. EMBO (Eur Mol Biol Organ) J 12:1597-1605.
51. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, and Lisanti MP (1998a) Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428:205-211.
52. Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, Windle JJ, Pestell RG, and Lisanti MP (1998b) Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem 273:20448-20455.
53. Engelman JA, Wycoff CC, Yasuhara S, Song KS, Okamoto T, and Lisanti MP (1997) Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272:16374-16381.
54. Engelman JA, Zhang XL, Galbiati F, Volonte D, Sotgia F, Pestell RG, Minetti C, Scherer PE, Okamoto T, and Lisanti MP (1998c) Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer's disease and muscular dystrophy. Am J Hum Genetics 63:1578-1587.
55. Engelman JA, Zhang XL, and Lisanti MP (1998d) Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett 436:403-410.
56. Engelman JA, Zhang XL, and Lisanti MP (1999) Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett 448:221-230.
57. Fagan KA, Smith KE, and Cooper DM (2000) Regulation of the Ca2+-inhibitable adenylyl cyclase type VI by capacitative Ca2+ entry requires localization in cholesterol-rich domains. J Biol Chem 275:26530-26537.
58. Fan JY, Carpentier J-L, van Obberghen E, Grunfeld C, Gorden P, and Orci L (1983) Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. J Cell Sci 61:219-230.
59. Feng Y, Venema VJ, Venema RC, Tsai N, Behzadian MA, and Caldwell RB (1999) VEGF-induced permeability increase is mediated by caveolae. Investig Ophthalmol Vis Sci 40:157-167.
60. Feron O, Belhhassen L, Kobzik L, Smith TW, Kelly RA, and Michel T (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271:22810-22814.
61. Feron O, Smith TW, Michel T, and Kelly RA (1997) Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem 272:17744-17748.
62. Fielding CJ, Bist A, and Fielding PE (1997) Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 94:3753-3758.
63. Fielding CJ, Bist A, and Fielding PE (1999) Intracellular cholesterol transport in synchronized human skin fibroblasts. Biochemistry 38:2506-2513.
64. Fielding CJ and Fielding PE (1997) Intracellular cholesterol transport. J Lipid Res 38:1503-1521.
65. Fielding CJ and Fielding PE (2000) Cholesterol and caveolae: structural and functional relationships. Biochim Biophys Acta 1529:210-222.
66. Fielding PE and Fielding CJ (1995) Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34:14288-14292.
67. Flucher BE, Andrews SB, and Daniels MP (1994) Molecular organization of transverse tubule/sarcoplasmic reticulum junctions during development of excitation-contraction coupling in skeletal muscle. Mol Biol Cell 5:1105-1118.
68. Fra AM, Masserini M, Palestini P, Sonnino S, and Simons K (1995a) A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett 375:11-14.
69. Fra AM, Williamson E, Simons K, and Parton RG (1994) Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J Biol Chem 269:30745-30748.
70. Fra AM, Williamson E, Simons K, and Parton RG (1995b) De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 92:8655-8659.
71. Frank PG, Pedraza A, Cohen DE, and Lisanti MP (2001) Adenovirus-mediated expression of caveolin-1 in mouse liver increases plasma high-density lipoprotein levels. Biochemistry 40:10892-10900.
72. Fujimoto T (1993) Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol 120:1147-1157.
73. Fujimoto T, Kogo H, Ishiguro K, Tauchi K, and Nomura R (2001) Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J Cell Biol 152:1079-1085.
74. Fujimoto T, Nakade S, Miyawaki A, Mikoshiba K, and Ogawa K (1992) Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol 119:1507-1513.
75. Fulton D, Fontana J, Sowa G, Gratton JP, Lin M, Li KX, Michell B, Kemp BE, Rodman D, and Sessa WC (2002) Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem 277:4277-4284.
76. Gabella G (1976) Quantitative morphological study of smooth muscle cells of the guinea-pig taenia coli. Cell Tissue Res 170:161-186.
77. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H, Kneitz B, Edelmann W, and Lisanti MP (2001a) Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex and T-tubule abnormalities. J Biol Chem 276:21425-21433.
78. Galbiati F, Razani B, and Lisanti MP (2001b) Emerging themes in lipid rafts and caveolae. Cell 106:403-411.
79. Galbiati F, Razani B, and Lisanti MP (2001c) Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 7:435-441.
80. Galbiati F, Volonte D, Brown AM, Weinstein DE, Ben-Ze'ev A, Pestell RG, and Lisanti MP (2000a) Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J Biol Chem 275:23368-23377.
81. Galbiati F, Volonte D, Engelman JA, Scherer PE, and Lisanti MP (1999a) Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem 274:30315-30321.
82. Galbiati F, Volonté D, Engelman JA, Watanabe G, Burk R, Pestell R, and Lisanti MP (1998) Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO (Eur Mol Biol Organ) J 17:6633-6648.
83. Galbiati F, Volonte D, Minetti C, Bregman DB, and Lisanti MP (2000b) Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3. J Biol Chem 275:37702-37711.
84. Galbiati F, Volonte D, Minetti C, Chu JB, and Lisanti MP (1999b) Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the Golgi complex. J Biol Chem 274:25632-25641.
85. Garcia-Cardena G, Fan R, Stern D, Liu J, and Sessa WC (1996a) Endothelial nitric oxide synthase is regulated by tyrsosine phosphorylation and interacts with caveolin-1. J Biol Chem 271:27237-27240.
86. Garcia-Cardena G, Martasek P, Siler-Masters BS, Skidd PM, Couet JC, Li S, Lisanti MP, and Sessa WC (1997) Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272:25437-25440.
87. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, and Sessa WC (1996b) Targeting of nitric oxide synthase to endothelilal cell caveolae via palmitoylation: implications for caveolae localization. Proc Natl Acad Sci USA 93:6448-6453.
88. Gerber GE, Mangroo D, and Trigatti BL (1993) Identification of high affinity membrane-bound fatty acid-binding proteins using a photoreactive fatty acid. Mol Cell Biochem 123:39-44.
89. Ghitescu L and Bendayan M (1992) Transendothelial transport of serum albumin: A quantitative immunocytochemical study. J Cell Biol 117:745-755.
90. Gil J (1983) Number and distribution of plasmalemmal vesicles in the lung. Fed Proc 42:2414-2418.
91. Gingras D, Gauthier F, Lamy S, Desrosiers RR, and Beliveau R (1998) Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains. Biochem Biophys Res Commun 247:888-893.
92. Glenney JR Jr (1989) Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem 264:20163-20166.
93. Glenney JR (1992) The sequence of human caveolin reveals identity with VIP 21, a component of transport vesicles. FEBS Lett 314:45-48.
94. Glenney JR Jr and Soppet D (1992) Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 89:10517-10521.
95. Glenney JR Jr and Zokas L (1989) Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J Cell Biol 108:2401-2408.
96. Graf GA, Connell PM, van der Westhuyzen DR, and Smart EJ (1999) The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into cavoelae. J Biol Chem 274:12043-12048.
97. Gumbleton M (2001) Caveolae as potential macromolecule trafficking compartments within alveolar epithelium. Adv Drug Deliv Rev 49:281-300.
98. Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, Lindroth M, Peterson KH, Magnusson KE, and Stralfors P (1999) Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 13:1961-1971.
99. Gustavsson J, Parpal S, and Stralfors P (1996) Insulin-stimulated glucose uptake involves the transition of glucose transporters to a caveolae-rich fraction within the plasma membrane: implications for type II diabetes. Mol Med 2:367-372.
100. Haasemann M, Cartaud J, Muller-Esterl W, and Dunia I (1998) Agonist-induced redistribution of bradykinin B2 receptor in caveolae. J Cell Sci 111:917-928.
101. Hagiwara Y, Sasaoka T, Araishi K, Imamura M, Yorifuji H, Nonaka I, Ozawa E, and Kikuchi T (2000) Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet 9:3047-3054.
102. Hailstones D, Sleer LS, Parton RG, and Stanley KK (1998) Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res 39:369-379.
103. Hayashi K, Matsuda S, Machida K, Yamamoto T, Fukuda Y, Nimura Y, Hayakawa T, and Hamaguchi M (2001) Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res 61:2361-2364.
104. Heino S, Lusa S, Somerharju P, Ehnholm C, Olkkonen VM, and Ikonen E (2000) Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci USA 97:8375-8380.
105. Henley JR, Krueger EW, Oswald BJ, and McNiven MA (1998) Dynamin-mediated internalization of caveolae. J Cell Biol 141:85-99.
106. Herrmann R, Straub V, Blank M, Kutzick C, Franke N, Jacob EN, Lenard HG, Kroger S, and Voit T (2000) Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet 9:2335-2340.
107. Huang CS, Zhou J, Feng AK, Lynch CC, Klumperman J, DeArmond SJ, and Mobley WC (1999) Nerve growth factor signaling in caveolae-like domains at the plasma membrane. J Biol Chem 274:36707-36714.
108. Ishikawa H (1968) Formation of elaborate networks of T-system tubules in cultured skeletal muscle with special reference to the T-system formation. J Cell Biol 38:51-66.
109. Jang IH, Kim JH, Lee BD, Bae SS, Park MH, Suh PG, and Ryu SH (2001) Localization of phospholipase C-gamma1 signaling in caveolae: importance in EGF-induced phosphoinositide hydrolysis but not in tyrosine phosphorylation. FEBS Lett 491:4-8.
110. Jenkins R, Takahashi S, DeLacey K, Bergstralh E, and Lieber M (1998) Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q and 18q in stage T3N0M0 prostate cancer. Genes Chromosomes Cancer 21:131-143.
111. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, Rothblat GH, Swaney JB, and Tall AR (1997) Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272:20982-20985.
112. Ju H, Venema VJ, Liang H, Harris MB, Zou R, and Venema RC (2000) Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae. Biochem J 351:257-264.
113. Ju H, Zou R, Venema VJ, and Venema RC (1997) Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 272:18522-18525.
114. Kamen B, Smith A, and Anderson RGW (1991) The folate receptor works in tandem with a probenecid-sensitive carrier in MA 104 cells in vitro. J Clin Investig 87:1442-1449.
115. Kaplan MR and Simoni RD (1985) Transport of cholesterol from the endoplasmic reticulum to the plasma membrane. J Cell Biol 101:446-453.
116. Kerr J, Leary JA, Hurst T, Shih YC, Antalis TM, Friedlander M, Crawford E, Khoo SK, Ward B, and Chenevix-Trench G (1996) Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Oncogene 13:1815-1818.
117. Kifor O, Diaz R, Butters R, Kifor I, and Brown EM (1998) The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells. J Biol Chem 273:21708-21713.
118. Ko YG, Liu P, Pathak RK, Craig LC, and Anderson RG (1998) Early effects of pp60(v-src) kinase activation on caveolae. J Cell Biochem 71:524-535.
119. Koleske AJ, Baltimore D, and Lisanti MP (1995) Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92:1381-1385.
120. Kurzchalia T, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, and Simons K (1992) VIP 21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J Cell Biol 118:1003-1014.
121. Kurzchalia TV and Parton RG (1999) Membrane microdomains and caveolae. Curr Opin Cell Biol 11:424-431.
122. Lasley RD, Narayan P, Uittenbogaard A, and Smart EJ (2000) Activated cardiac adenosine A(1) receptors translocate out of caveolae. J Biol Chem 275:4417-4421.
123. Latker CH, Shinowara NL, Miller JC, and Rapoport SI (1987) Differential localization of alkaline phosphatase in barrier tissues of the frog and rat nervous systems: a cytochemical and biochemical study. J Comp Neurol 264:291-302.
124. Lee SW, Reimer CL, Oh P, Campbell DB, and Schnitzer JE (1998) Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16:1391-1397.
125. Lencer WI, Hirst TR, and Holmes RK (1999) Membrane traffic and the cellular uptake of cholera toxin. Biochim Biophys Acta 1450:177-190.
126. Li S, Couet J, and Lisanti MP (1996a) Src tyrosine kinases, G alpha subunits and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271:29182-29190.
127. Li S, Galbiati F, Volonte D, Sargiacomo M, Engelman JA, Das K, Scherer PE, and Lisanti MP (1998) Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett 434:127-134.
128. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, and Lisanti MP (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270:15693-15701.
129. Li S, Seitz R, and Lisanti MP (1996b) Phosphorylation of caveolin by Src tyrosine kinases: The α-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem 271:3863-3868.
130. Li S, Song KS, and Lisanti MP (1996c) Expression and characterization of recombinant caveolin: Purification by poly-histidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J Biol Chem 271:568-573.
131. Lin JC, Scherer SW, Tougas L, Traverso G, Tsui LC, Andrulis IL, Jothy S, and Park M (1996) Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET. Oncogene 13:2001-2008.
132. Liou JY, Deng WG, Gilroy DW, Shyue SK, and Wu KK (2001) Colocalization and interaction of cydooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem 276:34975-34982.
133. Lisanti MP, Scherer P, Tang Z-L, and Sargiacomo M (1994a) Caveolae, caveolin and caveolin-rich membrane domains: A signalling hypothesis. Trends Cell Biol 4:231-235.
134. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z-L, Hermanoski-Vosatka A, Tu Y-H, Cook RF, and Sargiacomo M (1994b) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J Cell Biol 126:111-126.
135. Liu J, Garcia-Cardena G, and Sessa WC (1996a) Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35:13277-13281.
136. Liu J, Lee P, Galbiati F, Kitsis RN, and Lisanti MP (2001) Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. Am J Physiol Cell Physiol 280:C823-C835.
137. Liu J, Oh P, Horner T, Rogers RA, and Schnitzer JE (1997) Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J Biol Chem 272:7211-7222.
138. Liu P and Anderson RGW (1995) Compartmentalized production of ceramide at the cell surface. J Biol Chem 270:27179-27185.
139. Liu P, Ying Y, Ko Y-G, and Anderson RGW (1996b) Localization of the PDGF-stimulated phosphorylation cascade to caveolae. J Biol Chem 271:10299-10303.
140. Londos C, Brasaemle DL, Schultz CJ, Segrest JP, and Kimmel AR (1999) Perilipins, ADRP and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol 10:51-58.
141. Lu ML, Schneider MC, Zheng Y, Zhang X, and Richie JP (2001) Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276:13442-13451.
142. Luetterforst R, Stang E, Zorzi N, Carozzi A, Way M, and Parton RG (1999) Molecular characterization of caveolin association with the Golgi complex: identification of a cis-Golgi targeting domain in the caveolin molecule. J Cell Biol 145:1443-1459.
143. Lupu C, Goodwin CA, Westmuckett AD, Emeis JJ, Scully MF, Kakkar VV, and Lupu F (1997) Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol 17:2964-2974.
144. Macleod KF and Jacks T (1999) Insights into cancer from transgenic mouse models. J Pathol 187:43-60.
145. Martens JR, Sakamoto N, Sullivan SA, Grobaski TD, and Tamkun MM (2001) Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem 276:8409-8414.
146. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, Nonaka I, Arahata K, and Brown RH Jr (2001) The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 10:1761-1766.
147. Matveev S, Uittenbogaard A, van Der Westhuyzen D, and Smart EJ (2001) Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur J Biochem 268:5609-5616.
148. Matveev S, van der Westhuyzen DR, and Smart EJ (1999) Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J Lipid Res 40:1647-1654.
149. Mayor S, Sabharanjak S, and Maxfield FR (1998) Cholesterol-dependent retention of GPI-anchored proteins in endosomes. EMBO (Eur Mol Biol Organ) J 17:4626-4638.
150. McIntosh DP and Schnitzer JE (1999) Caveolae require intact VAMP for targeted transport in vascular endothelium. Am J Physiol 277:H2222-H2232.
151. 2+-calmodulin and caveolin. J Biol Chem 272:15583-15586.
152. Michel JB, Feron O, Sase K, Prabhakar P, and Michel T (1997b) Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 272:25907-25912.
153. Millan J, Puertollano R, Fan L, and Alonso MA (1997a) Caveolin and MAL, two protein components of internal detergent-insoluble membranes, are in distinct lipid microenvironments in MDCK cells. Biochem Biophys Res Commun 233:707-712.
154. Millan J, Puertollano R, Fan L, Rancano C, and Alonso MA (1997b) The MAL proteolipid is a component of the detergent-insoluble membrane subdomains of human T-lymphocytes. Biochem J 321:247-252.
155. Mineo C and Anderson RG (1996) A vacuolar-type proton ATPase mediates acidification of plasmalemmal vesicles during potocytosis. Exp Cell Res 224:237-242.
156. Mineo C, Gill GN, and Anderson RG (1999) Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem 274:30636-43.
157. Mineo C, James GL, Smart EJ, and Anderson RGW (1996) Localization of EGF-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 271:11930-11935.
158. Minetti C, Bado M, Broda P, Sotgia F, Bruno C, Galbiati F, Volonte D, Lucania G, Pavan A, Bonilla E, et al. (2002) Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am J Pathol 160:265-270.
159. Minetti C, Sotogia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco P, Egeo A, Donati MA, et al. (1998) Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 18:365-368.
160. Mobley BA and Eisenberg BR (1975) Sizes of components in frog skeletal muscle measured by methods of stereology. J Gen Physiol 66:31-45.
161. Monier S, Dietzen DJ, Hastings WR, Lublin DM, and Kurzchalia TV (1996) Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett 388:143-149.
162. Monier S, Parton RG, Vogel F, Behlke J, Henske A, and Kurzchalia T (1995) VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol Biol Cell 6:911-927.
163. Montesano R, Roth J, Robert A, and Orci L (1982) Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature (Lond) 296:651-653.
164. Mora R, Bonilha VL, Marmorstein A, Scherer PE, Brown D, Lisanti MP,
165. Murata M, Peranen J, Schreiner R, Weiland F, Kurzchalia T, and Simons K (1995) VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 92:10339-10343.
166. Napolitano LM (1963) The differentiation of white adipose cells. An electron microscope study. J Cell Biol 18:663-679.
167. Nystrom FH, Chen H, Cong LN, Li Y, and Quon MJ (1999) Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocrinol 13:2013-2024.
168. Oh P, McIntosh DP, and Schnitzer JE (1998) Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 141:101-114.
169. Oh P and Schnitzer JE (2001) Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell 12:685-698.
170. Okada SS, Tomaszewski JE, and Barnathan ES (1995) Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro. Exp Cell Res 217:180-187.
171. Okamoto T, Schlegel A, Scherer PE, and Lisanti MP (1998) Caveolins, a family of scaffolding proteins for organizing "pre-assembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422.
172. Okamoto Y, Ninomiya H, Miwa S, and Masaki T (2000) Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells. J Biol Chem 275:6439-6446.
173. Ostermeyer AG, Paci JM, Zeng Y, Lublin DM, Munro S, and Brown DA (2001) Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets. J Cell Biol 152:1071-1078.
174. Ostrom RS, Gregorian C, Drenan RM, Xiang Y, Regan JW, and Insel PA (2001) Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem 276:42063-42069.
175. Ostrom RS, Post SR, and Insel PA (2000a) Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). J Pharmacol Exp Ther 294:407-412.
176. Ostrom RS, Violin JD, Coleman S, and Insel PA (2000b) Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol 57:1075-1079.
177. Page E, Upshaw-Earley J, and Goings GE (1994) Localization of atrial natriuretic peptide in caveolae of in situ atrial myocytes. Circ Res 75:949-954.
178. Palade GE (1953) Fine structure of blood capillaries. J Appl Physiol 24:1424-1436.
179. Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A, and Lisanti MP (2001) Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry 40:3354-3362.
180. Park H, Go YM, Darji R, Choi JW, Lisanti MP, Maland MC, and Jo H (2000) Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase. Am J Physiol Heart Circ Physiol 278:H1285-H1293.
181. Parolini I, Sargiacomo M, Galbiati F, Rizzo G, Grignani F, Engelman JA, Okamoto T, Ikezu T, Scherer PE, Mora R, et al. (1999) Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex. J Biol Chem 274:25718-25725.
182. Parton RG (1996) Caveolae and caveolins. Curr Opin Cell Biol 8:542-548.
183. Parton RG, Joggerst B, and Simons K (1994) Regulated internalization of caveolae. J Cell Biol 127:1199-1215.
184. Parton RG, Way M, Zorzi N, and Stang E (1997) Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol 136:137-154.
185. Pawson T and Scott JD (1997) Signaling through scaffold, anchoring and adaptor proteins. Science (Wash DC) 278:2075-2080.
186. Pelkmans L, Kartenbeck J, and Helenius A (2001) Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3:473-483.
187. Pike LJ and Casey L (1996) Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J Biol Chem 271:26453-26456.
188. Pike LJ and Miller JM (1998) Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. J Biol Chem 273:22298-22304.
189. Pol A, Luetterforst R, Lindsay M, Heino S, Ikonen E, and Parton RG (2001) A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J Cell Biol 152:1057-1070.
190. Predescu D, Horvat R, Predescu S, and Palade GE (1994) Transcytosis in the continuous endothelium of the myocardial microvasculature is inhibited by N-ethylmaleimide. Proc Natl Acad Sci USA 91:3014-3018.
191. Predescu D, Predescu S, McQuistan T, and Palade GE (1998) Transcytosis of alphalacidic glycoprotein in the continuous microvascular endothelium. Proc Natl Acad Sci USA 95:6175-6180.
192. Predescu SA, Predescu DN, and Palade GE (1997) Plasmalemmal vesicles function as transcytotic carriers for small proteins in the continuous endothelium. Am J Physiol 272:H937-H949.
193. Predescu SA, Predescu DN, and Palade GE (2001) Endothelial transcytotic machinery involves supramolecular protein-lipid complexes. Mol Biol Cell 12:1019-1033.
194. Prior IA, Harding A, Yan J, Sluimer J, Parton RG, and Hancock JF (2001) GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol 3:368-375.
195. Razani B, Altschuler Y, Zhu L, Pestell RG, Mostov KE, and Lisanti MP (2000a) Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry 39:13916-13924.
196. Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, and Lisanti MP (2002a) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 277:8635-8647.
197. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, et al. (2001a) Caveolin-1 null mice are viable, but show evidence of hyper-proliferative and vascular abnormalities. J Biol Chem 276:38121-38138.
198. Razani B, Rubin CS, and Lisanti MP (1999) Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. J Biol Chem 274:26353-26360.
199. Razani B, Schlegel A, and Lisanti MP (2000b) Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J Cell Sci 113, 2103-2109.
200. Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H Jr, Christ GJ, Edelmann W, and Lisanti MP (2002b) Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22:2329-2344.
201. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, and Lisanti MP (2001b) Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem 276:6727-6738.
202. Riddell DR, Sun XM, Stannard AK, Soutar AK, and Owen JS (2001) Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane. J Lipid Res 42:998-1002.
203. Robbins S, Quintrell N, and Bishop JM (1995a) Differential palmitoylation of the two isoforms of the Src family kinase, HCK, affects their localization to caveolae (Abstract). J Cell Biochem 19A (Suppl):27.
204. Robbins SM, Quintrell NA, and Bishop MJ (1995b) Myryistoylation and differential palmitoylation of the HCK protein tyrosine kinases govern their attachment to membranes and association with caveolae. Mol Cell Biol 15:3507-3515.
205. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, and Sandvig K (1999) Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 10:961-974.
206. Roettger BF, Rentsch RU, Pinon D, Holicky E, Hadac E, Larkin JM, and Miller LJ (1995) Dual pathways of internalization of the cholecystokinin receptor. J Cell Biol 128:1029-1041.
207. Ros-Baro A, Lopez-Iglesias C, Peiro S, Bellido D, Palacin M, Zorzano A, and Camps M (2001) Lipid rafts are required for GLUT4 internalization in adipose cells. Proc Natl Acad Sci USA 98:12050-12055.
208. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, and Anderson RG (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682.
209. Rothberg KG, Ying YS, Kolhouse JF, Kamen BA, and Anderson RG (1990) The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway. J Cell Biol 110:637-649.
210. Roy S, Luetterforst R, Harding A, Apolloni A, Etheridge M, Stang E, Rolls B, Hancock JF, and Parton RG (1999) Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat Cell Biol 1:98-105.
211. Rybin VO, Xu X, Lisanti MP, and Steinberg SF (2000) Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 275:41447-41457.
212. Rybin VO, Xu X, and Steinberg SF (1999) Activated protein kinase C isoforms target to cardiomyocyte caveolae: stimulation of local protein phosphorylation. Circ Res 84:980-988.
213. Sabourin T, Bastien L, Bachvarov DR, and Marceau F (2002) Agonist-induced translocation of the kinin B(1) receptor to caveolae-related rafts. Mol Pharmacol 61:546-553.
214. Sargiacomo M, Scherer PE, Tang Z-L, Kubler E, Song KS, Sanders MC, and Lisanti MP (1995) Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 92:9407-9411.
215. Sargiacomo M, Sudol M, Tang Z-L, and Lisanti MP (1993) Signal transducing molecules and GPI-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122:789-807.
216. Scheel J, Srinivasan J, Honnert U, Henske A, and Kurzchalia TV (1999) Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans. Nat Cell Biol 1:127-129.
217. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, and Lisanti MP (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272:29337-29346.
218. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Corley-Mastick C, and Lodish HF (1994) Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol 127:1233-1243.
219. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, and Lisanti MP (1996) Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93:131-135.
220. Scherer PE, Tang Z-L, Chun MC, Sargiacomo M, Lodish HF, and Lisanti MP (1995) Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 270:16395-16401.
221. Schiaffino S, Cantini M, and Sartore S (1977) T-system formation in cultured rat skeletal tissue. Tissue Cell 9:437-446.
222. Schlegel A and Lisanti MP (2000) A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. J Biol Chem 275:21605-21617.
223. Schlegel A, Schwab R, Scherer PE, and Lisanti MP (1999a) A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. J Biol Chem 274:22660-22667.
224. Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, and Lisanti MP (1999b) Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha. J Biol Chem 274:33551-33556.
225. Schmidt A, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, et al. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267:14987-14997.
226. Schnitzer JE (2001) Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev 49:265-280.
227. Schnitzer JE, Allard J, and Oh P (1995a) NEM inhibits transcytosis, endocytosis and capillary permeability: implication of caveolae fusion in endothelia. Am J Physiol 268:H48-H55.
228. Schnitzer JE, Liu J, and Oh P (1995b) Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins and GTPases. J Biol Chem 270:14399-14404.
229. Schnitzer JE, Oh P, Jacobson BS, and Dvorak AM (1995c) Caveolae from luminal plasmalemma of rat lung endothelium: microdomains enriched in caveolin, Ca2+-ATPase and inositol triphosphate receptor. Proc Natl Acad Sci USA 92:1759-1763.
230. Schnitzer JE, Oh P, and McIntosh DP (1996) Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science (Wash DC) 274:239-242.
231. Schnitzer JE, Oh P, Pinney E, and Allard J (1994) Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endoctytosis and capillary permeability of select macromolecules. J Cell Biol 127:1217-1232.
232. Schubert W, Frank PG, Razani B, Park DS, Chow CW, and Lisanti MP (2001) Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem 276:48619-48622.
233. Schwab W, Gavlik JM, Beichler T, Funk RH, Albrecht S, Magdolen V, Luther T, Kasper M, and Shakibaei M (2001) Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and beta 1-integrin. Histochem Cell Biol 115:317-323.
234. Schwab W, Kasper M, Gavlik JM, Schulze E, Funk RH, and Shakibaei M (2000) Characterization of caveolins from human knee joint catilage: expression of caveolin-1, -2 and -3 in chondrocytes and association with integrin beta1. Histochem Cell Biol 113:221-225.
235. Schwencke C, Okumura S, Yamamoto M, Geng YJ, and Ishikawa Y (1999) Colocalization of beta-adrenergic receptors and caveolin within the plasma membrane. J Cell Biochem 75:64-72.
236. Setoguti T, Takagi M, and Kato K (1980) Ultrastructural localization of phosphatases in the rat parathyroid gland. Arch Histol Jpn 43:45-56.
237. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, and Michel T (1996) Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518-6522.
238. Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, and Lublin DM (1994) Cysteine-3 of Src family tyrosine kinases determines palmitoylation and localization in caveolae. J Cell Biol 126:353-363.
239. Shin JS, Gao Z, and Abraham SN (2000) Involvement of cellular caveolae in bacterial entry into mast cells. Science (Wash DC) 289:785-788.
240. Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, and Smith DI (1997) Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene 15:2727-2733.
241. Simionescu N, Simionescu M, and Palade GE (1975) Permeability of muscle capillaries to small heme-peptides: Evidence for the existence of patent transendothelial channels. J Cell Biol 64:586-607.
242. Simons K and Ikonen E (2000) How cells handle cholesterol. Science (Wash DC) 290:1721-1726.
243. Simons K and Toomre D (2000) Lipid Rafts and Signal Transduction. Nat Rev Mol Cell Biol 1:31-39.
244. Singer SJ and Nicolson GL (1972) The fluid mosaic model of the structure of cell membranes. Science (Wash DC) 175:720-731.
245. Smart E, Ying Y-S, Conrad P, and Anderson RGW (1994) Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol 127:1185-1197.
246. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, and Lisanti MP (1999) Caveolins, liquid-ordered domains and signal transduction. Mol Cell Biol 19:7289-7304.
247. Smart EJ, Ying Y-S, Donzell WC, and Anderson RGW (1996) A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem 271:29427-29435.
248. Smith RM, Harada S, Smith JA, Zhang S, and Jarett L (1998) Insulin-induced protein tyrosine phosphorylation cascade and signalling molecules are localized in a caveolin-enriched cell membrane domain. Cell Signal 10:355-362.
249. Song KS, Li S, Okamoto T, Quilliam L, Sargiacomo M, and Lisanti MP (1996a) Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes. J Biol Chem 271:9690-9697.
250. i1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation. Cell Mol Biol (Noisy-Le-Grand) 43:293-303.
251. Song KS, Scherer PE, Tang Z-L, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, and Lisanti MP (1996b) Expression of caveolin-3 in skeletal, cardiac and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271:15160-15165.
252. Song KS, Tang Z-L, Li S, and Lisanti MP (1997b) Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homotypic caveolin-caveolin interactions. J Biol Chem 272:4398-4403.
253. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, and Lisanti MP (2000) Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 275:38048-38058.
254. Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, Capozza F, Schubert AL, Minetti C, Buckley JT, and Lisanti MP (2002) Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Mol Cell Biol 22:3905-3926.
255. Sowa G, Pypaert M, and Sessa WC (2001) Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 98:14072-14077.
256. Spisni E, Griffoni C, Santi S, Riccio M, Marulli R, Bartolini G, Toni M, Ullrich V, and Tomasi V (2001) Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. Exp Cell Res 266:31-43.
257. Stahl A and Mueller BM (1995) The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 129:335-344.
258. Stan RV, Ghitescu L, Jacobson BS, and Palade GE (1999) Isolation, cloning and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol 145:1189-1198.
259. Stang E, Kartenbeck J, and Parton RG (1997) Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol Biol Cell 8:47-57.
260. Steinberg SF (2001) G protein-coupled receptor kinases: gotta real kure for heart failure. J Am Coll Cardiol 38:541-545.
261. Stitt AW, Burke GA, Chen F, McMullen CB, and Vlassara H (2000) Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains. FASEB J 14:2390-2392.
262. Sunada Y, Ohi H, Hase A, Hosono T, Arata S, Higuchi S, Matsumura K, and Shimizu T (2001) Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum Mol Genet 10:173-178.
263. Tachibana T and Nawa T (1992) Ultrastructural localization of Ca(++)-ATPases in Meissner's corpuscle of the Mongolian gerbil. Arch Histol Cytol 55:375-379.
264. Takei K and Haucke V (2001) Clathrin-mediated endocytosis: membrane factors pull the trigger. Trends Cell Biol 11:385-391.
265. Tang Z-L, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, and Lisanti MP (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-2261.
266. Tateyama M, Aoki M, Nishino I, Hayashi YK, Sekiguchi S, Shiga Y, Takahashi T, Onodera Y, Haginoya K, Kobayashi K, et al. (2002) Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 58:323-325.
267. Thiele C, Hannah MJ, Fahrenholz F, and Huttner WB (2000) Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2:42-49.
268. Timme TL, Goltsov A, Tahir S, Li L, Wang J, Ren C, Johnston RN, and Thompson TC (2000) Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene 19:3256-3265.
269. Trigatti BL, Anderson RG, and Gerber GE (1999) Identification of caveolin-1 as a fatty acid binding protein. Biochem Biophys Res Commun 255:34-39.
270. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, and Smart EJ (2000) High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem 275:11278-11283.
271. Uittenbogaard A and Smart EJ (2000) Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation and rapid transport of cholesterol to caveolae. J Biol Chem 275:25595-25599.
272. Uittenbogaard A, Ying Y, and Smart EJ (1998) Characterization of a cytosolic heat-shock protein-caveolin chaperone complex: involvement in cholesterol trafficking. J Biol Chem 273:6525-6532.
273. Urbani L and Simoni RD (1990) Cholesterol and vesicular stomatitis virus G protein take separate routes from the endoplasmic reticulum to the plasma membrane. J Biol Chem 265:1919-1923.
274. Vaghy PL, Fang J, Wu W, and Vaghy LP (1998) Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett 431:125-127.
275. Venema VJ, Ju H, Zou R, and Venema RC (1997) Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 272:28187-28190.
276. Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, and Lisanti MP (1999) Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem 274:12702-12709.
277. Vorgerd M, Ricker K, Ziemssen F, Kress W, Goebel HH, Nix WA, Kubisch C, Schoser BG, and Mortier W (2001) A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 57, 2273-2277.
278. Wary KK, Mariott IA, Zurzolo C, and Giancotti FG (1998) A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94:625-634.
279. Waugh MG, Lawson D, Tan SK, and Hsuan JJ (1998) Phosphatidylinositol 4-phosphate synthesis in immunoisolated caveolae-like vesicles and low buoyant density non-caveolar membranes. J Biol Chem 273:17115-17121.
280. Way M and Parton R (1995) M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 376:108-112.
281. Wei Y, Yang X, Liu Q, Wilkins JA, and Chapman HA (1999) A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 144:1285-1294.
282. Yamada E (1955) The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1:445-458.
283. Yamamoto M, Toya Y, Jensen RA, and Ishikawa Y (1999) Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp Cell Res 247:380-388.
284. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers M, and Ishikawa Y (1998) Caveolin is an activator of insulin receptor signaling. J Biol Chem 273:26962-26968.
285. Zenklusen JC, Bieche I, Lidereau R, and Conti CJ (1994a) (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA 91:12155-12158.
286. Zenklusen JC, Conti CJ, and Green ED (2001) Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. Nat Genet 27:392-398.
287. Zenklusen JC, Thompson JC, Klein-Szanto AJ, and Conti CJ (1995a) Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res 55:1347-1350.
288. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, and Conti CJ (1994b) Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-6373.
289. Zenklusen JC, Weitzel JN, Ball HG, and Conti CJ (1995b) Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene 11:359-363.
290. Zhou SL, Stump D, Sorrentino D, Potter BJ, and Berk PD (1992) Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43-kDa plasma membrane fatty acid-binding protein. J Biol Chem 267:14456-61.
291. Zundel W, Swiersz LM, and Giaccia A (2000) Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol Cell Biol 20:1507-1514.